# Prevalence of CYP3A5 Polymorphisms in the Donors and ABCB1 Polymorphisms in the Recipients Undergoing Pediatric Liver Transplant and Their Influence on Tacrolimus Levels and Graft Function.

> **NCT06361732** · — · UNKNOWN · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 80 (estimated)

## Conditions studied

- Pediatric Liver Transplant

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT06361732
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-17
- **Primary completion:** 2024-10-30
- **Final completion:** 2024-10-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2024-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06361732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06361732, "Prevalence of CYP3A5 Polymorphisms in the Donors and ABCB1 Polymorphisms in the Recipients Undergoing Pediatric Liver Transplant and Their Influence on Tacrolimus Levels and Graft Function.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06361732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*